Efficacy of a pharmacist-led cardiovascular risk reduction clinic for diabetic patients with and without mental health conditions

Preventive Cardiology

Volumn 11, Issue 4, 2008, Pages 195-200

  Taveira, Tracey H ^a,b,d   Pirraglia, Paul A ^a,c   Cohen, Lisa B ^a,b   Wu, Wen Chih ^a,c  

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c BROWN UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEPRESSION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PERSONALITY DISORDER; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RISK REDUCTION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SMOKING CESSATION; SOCIAL PHOBIA; SYSTOLIC BLOOD PRESSURE; TOBACCO DEPENDENCE; TREATMENT INDICATION; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; FOLLOW UP; HOSPITALIZATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT DEPARTMENT; PHARMACY; PROBABILITY; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; TREATMENT OUTCOME; VETERAN;

AGED; AMBULATORY CARE FACILITIES; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; LINEAR MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHARMACEUTICAL SERVICES; PROBABILITY; PSYCHOTROPIC DRUGS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VETERANS;

EID: 66949168485     PISSN: 1520037X     EISSN: 17517141     Source Type: Journal    
DOI: 10.1111/j.1751-7141.2008.00008.x     Document Type: Article

References (27)

1. Musselman DL, Evans LD, Nemeroff BC. The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55(7):580-592.
2. Brown S, Barraclough B, Inskip H. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177(3):212-217.
3. Kreyenbuhl J, Dickerson FB, Medoff DR, et al. Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness. J Nerv Ment Dis. 2006;194(6):404-410.
4. Frayne SM, Halanych JH, Miller DR, et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med. 2005;165(22):2631-2638.
5. Fenton JJ, Von Korff M, Lin EHB, et al. Quality of preventive care for diabetes: Effects of visit frequency and competing demands. Ann Fam Med. 2006;4(1):32-39.
6. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects. CNS Drugs. 2005;19:1-93.
7. Taveira T, Wu W, Martin O, et al. Pharmacist-led cardiac risk reduction model. Prev Cardiol. 2006;9(Fall 4):202-208.
8. Martin O, Wu W, Schleinitz M, et al. Effectiveness of pharmacist-coordinated care to reduce cardiovascular risk factors in patients with diabetes mellitus. Circulation. 2004;109:e51.
9. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
10. American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care. 2006;29(suppl 1):S4-S42.
11. Janz N, Champion V, Strecher V. Health Behavior and Health Education: Theory, Research and Practice in Health Behavior and Health Education, 3rd ed. San Francisco: Jonh Wiley and Sons Inc.; 2002.
12. Mikhail B. The health belief model: A review and critical evaluation of the model, research and practice. ANS Nurs Sci. 1981;4:65-82.
13. Fagerstrom K.O. Measuring degree of physical dependency to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978;3:235-241.
14. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: Toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390-395.
15. Berkman L, Glass T. Social Integration, Social Networks, Social Support, and Health. New York: Oxford Press; 2000.
16. U.S. Department of Veterans Affairs. Pharmacy benefits management strategic healthcare group treatment guidelines. http://www.vapbm.org/ PBM/treatment.htm. Accessed August 8, 2005.
17. Stevens RJ, Kothari V, Adler AI, et al. The UKPDS risk engine: A model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci. 2001;101(6):671-679.
18. Association AP. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1995.
19. Goldman L. Medical illness in patients with schizophrenia. J Clin Psychiatry. 1999;60(S21):10-15.
20. Muir-Cochrane E. Medical co-morbidity risk factors and barriers to care for people with schizophrenia. J Psychiatr Ment Health Nurs. 2006;13(4):447-452.
21. Gehi A, Haas D, Pipkin S, et al. Depression and medication adherence in outpatients with coronary heart disease: Findings from the Heart and Soul Study. Arch Intern Med. 2005;165(21):2508-2513.
22. Heaney C, Israel B. Health behavior and health education theory, research and practice. In: Glanz K, Rimer B, Lewis F, eds. Social Networks and Social Support, 3rd ed. San Francisco: John Wiley & Sons, Inc.; 2002:185-206.
23. Wagner E, Austin B, Davis C, et al. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20:64-78.
24. Wright C, Osborn D, Nazareth I, et al. Prevention of coronary heart disease in people with severe mental illnesses: A qualitative study of patient and professionals' preferences for care. BMC Psychiatry. 2006;6(1):16.
25. Prochaska J, Redding C, Evers K. The Transtheoretical Model and Stages of Change, 3rd ed. San Fransico: John Wiley & Sons, Inc; 2002.
26. Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. New Jersey: Prentice Hall; 1986.
27. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-2107.